Thrombosis
Products Related to Thrombosis(52)
- GC60326Rivaroxaban D4CAS: 1132681-38-9Purity: >98%
An internal standard for the quantification of rivaroxaban
- GC90603Tat-CIRP (trifluoroacetate salt)Purity: >95.00%
A peptide inhibitor of the MD-2-CIRP protein-protein interaction
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC60326 | Rivaroxaban D4 | 1132681-38-9 | >98% | |
An internal standard for the quantification of rivaroxaban | ||||
| GC72527 | S-(-)-Warfarin | 5543-57-7 | - | |
| GC90603 | Tat-CIRP (trifluoroacetate salt) | - | >95.00% | |
A peptide inhibitor of the MD-2-CIRP protein-protein interaction | ||||
| GC91898 | BI SF3 (hydrochloride) | 1801257-24-8 | >95.00% | |
BI SF3 is a synthetic intermediate. | ||||